Content Type: Research Publications

Diabetes Drugs: List Price Increases Were Not Always Reflected in Net Price; Impact of Brand Competition Unclear

March 15, 2026

Public Funding for Transformative Drugs: The Case of Sofosbuvir

March 15, 2026

Correlation Between Changes in Brand-Name Drug Prices and Patient Out-Of-Pocket Costs

March 15, 2026

Assessment of Variation in State Regulation of Generic Drug and Interchangeable Biologic Substitutions

March 15, 2026

Prospects for Enforcing Prohibitions on Off-Label Drug Promotion After United States v. Caronia: An Analysis of Litigated Cases

March 15, 2026

An Overview of Vaccine Development, Approval, and Regulation, with Implications for COVID-19

March 15, 2026

Repurposing Existing Drugs for New Uses: A Cohort Study of the Frequency of FDA-Granted New Indication Exclusivities Since 1997

March 15, 2026

Market Exclusivity Length for Drugs with New Generic or Biosimilar Competition, 2012-2018

March 15, 2026

Factors Affecting Buprenorphine Utilization and Spending in Medicaid, 2002-2018

March 15, 2026

Buprenorphine for Opioid Use Disorder: The Role of Public Funding in Its Development

March 15, 2026

A Correlation Analysis to Assess Event-Free Survival as a Trial-Level Surrogate for Overall Survival in Early Breast Cancer

March 15, 2026

Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation

March 15, 2026